Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

KPCB leads Breathe Technologies' $15mm Series B

Executive Summary

Breathe Technologies (respiratory disease devices) raised $15mm in its Series B financing, which was led by Kleiner, Perkins, Caufield & Byers and included returning shareholders Synergy Partners International, Delphi Ventures, and Life Science Angels. A KPCB partner now sits on the company's board.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies